Remove Biopharma Remove Healthcare Provider Remove Patients
article thumbnail

Polypharmacy is a Health Killer: Personalized Medication Management is the Answer

MedCity News

We cannot change the fact that some patients must take multiple drugs, but we can certainly change how we manage it with careful coordination and communication among healthcare providers, and personalized medicine practices such as pharmacogenomics.

article thumbnail

Redefining Clinical Development of Obesity Drugs: What Does Success Look Like? 

MedCity News

As multi-billion investment continues to pour into the R&D of future obesity medications, the need for evidence generation of health benefits beyond short-term weight loss will be critical to the decision-making of healthcare providers and payers. appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can Herbal Alternatives Ease the Economic Burden of Weight Loss Drugs?

MedCity News

For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the side effects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. appeared first on MedCity News.

article thumbnail

Access solutions: the missing link that prevents biopharma innovation from reaching patients

pharmaphorum

Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. We believe that innovation in patient access models is the necessary catalyst to aid patients in starting on and staying on the therapies they need to improve their lives.

article thumbnail

What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder

MedCity News

The goal was simple: provide access and focused support to patients remotely while simultaneously relieving overtaxed healthcare facilities. Combined, DTx and DCTs improve patient recruitment, retention, and access, allowing researchers to pull from underserved communities, including rural populations.

article thumbnail

Global Biopharma Launches in the New World Order

PM360

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. Despite the rapid advances that have enabled these innovations, healthcare systems and commercial infrastructure aren’t keeping pace. In oncology, it’s 47% less.

article thumbnail

FOCUS ON: Connected TV

PM360

From connecting with patients by interactive ads to dabbling into cross-platform integration, here is what our specialists had to say. What are new and effective ways of engaging patients who are now using streaming services? Biopharma marketers are following their audiences and investment in this channel continues to increase.

Media 105